Canada Algernon receives approval to conduct DMT study in the Netherlands New clinical research will assess efficacy of IV formulation for the treatment of strokes Rowan DunneSeptember 12, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Canada Clearmind’s psychoactive drug shows positive results for cocaine use disorder Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency Rowan DunneAugust 26, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Culture Sisters in Psychedelics host inaugural summit in Vancouver this September Upcoming event said to feature powerful female speakers from broad cross-section of practices and expertise Rowan DunneAugust 10, 2022
Canada PharmAla Biotech initiates MDMA supplier agreement with InterVivo Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses Rowan DunneAugust 5, 2022
Psychedelics Delic Holdings highlights financial success and continues expanding KWC Canadian company continues to develop its presence in the clinical psychedelic sector Rowan DunneJuly 21, 2022
Canada Nextleaf adds to its Glacial Gold catalogue Company launches 3:1 CBD vape in berry lemonade flavour Rowan DunneJuly 13, 2022
Psychedelics Numinus to offer ketamine-assisted psychotherapy B.C. Mental health care company develops passion inspired by Utah pioneers Rowan DunneJune 27, 2022
Business HAVN enters psilocybin mushroom supply agreement with Jamaican cannabis producer Green Stripe was one of the first cannabis companies to get established in Jamaica Natalia Buendia CalvilloJune 7, 2022